Clinical Trial Update: Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide [Phase 1]

View source ↗

Summary

This Phase 1 study reports on the feasibility and reproducibility of measuring colorectal sensation during distention using a barostat, and evaluates octreotide…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Sandostatin (Octreotide acetate)

Snippet

Sponsor: Novartis | Conditions: Irritable Bowel Syndrome (IBS) | Phase 1 | Status: COMPLETED